HTG Molecular Diagnostics Reports Fourth Quarter and Full Year 2016 Results
Mar 23, 2017 20:03 pm UTC| Business
TUCSON, Ariz., March 23, 2017 -- HTG Molecular Diagnostics, Inc. (NASDAQ:HTGM), a provider of instruments, reagents and services for molecular profiling applications, today reported financial results for the fourth...
Sportsman’s Warehouse Holdings, Inc. Appoints Jon Barker as President and Chief Operating Officer
Mar 23, 2017 20:02 pm UTC| Business
MIDVALE, Utah, March 23, 2017 -- Sportsman’s Warehouse Holdings,Inc. ("Sportsman’s" or the “Company”) (Nasdaq:SPWH) today announced that Jon Barker has been named President and Chief Operating Officer of Sportsman’s...
Sportsman's Warehouse Holdings, Inc. Announces Fourth Quarter and Fiscal Year 2016 Financial Results
Mar 23, 2017 20:01 pm UTC| Business
MIDVALE, Utah, March 23, 2017 -- Sportsman's Warehouse Holdings, Inc. ("Sportsman's" or the “Company”) (Nasdaq:SPWH) today announced financial results for the thirteen weeks and fifty-two weeks ended January 28, 2017. ...
OpGen Announces 2016 Fourth Quarter and Year End Financial Results
Mar 23, 2017 20:01 pm UTC| Business
GAITHERSBURG, Md., March 23, 2017 -- OpGen, Inc. (NASDAQ:OPGN) today reported financial and operational results for the fourth quarter and year endedDecember 31, 2016 and summarized 2016 business highlights. Total...
Mar 23, 2017 20:01 pm UTC| Business
TUCSON, Ariz., March 23, 2017 -- HTG Molecular Diagnostics, Inc. (Nasdaq:HTGM) (“HTG”), a provider of instruments, reagents, and services for molecular profiling applications, today announced that its HTGEdgeSeq...
Mar 23, 2017 20:01 pm UTC| Business
SEATTLE, March 23, 2017 -- NanoString Technologies, Inc. (NASDAQ:NSTG), a provider of life science tools for translational research and molecular diagnostic products, today announced the commercial launch of nCounter®...
CymaBay Reports Fourth Quarter and Year End 2016 Financial Results
Mar 23, 2017 20:01 pm UTC| Business
NEWARK, Calif., March 23, 2017 -- CymaBay Therapeutics, Inc. (NASDAQ:CBAY), a clinical-stage biopharmaceutical company developing therapies to treat specialty and orphan diseases with high unmet medical need, today...